Description:

SOUTHWEST ONCOLOGY GROUP S0600 CONCOMITANT MEDICATION FORM Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=258561E9-CE1C-6F0C-E044-0003BA3F9857

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=258561E9-CE1C-6F0C-E044-0003BA3F9857
Keywords:
  1. 8/27/12 8/27/12 -
  2. 1/8/15 1/8/15 - Martin Dugas
Uploaded on:

January 8, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Colorectal Cancer NCT00499369 Treatment - SOUTHWEST ONCOLOGY GROUP S0600 CONCOMITANT MEDICATION FORM - 2582968v1.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP S0600 CONCOMITANT MEDICATION FORM
    1. No Instruction available.
Header
Unnamed Module 2
Is patient on anti-hypertensive therapy
Unnamed Module 2
Is the patient on anticoagulant therapy
Anti-Coagulant Drugs
Unnamed Module 2
Is the patient on magnesium supplements
Route of Administration
Comments

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial